Table 5.

ELISpot data with tumor cell line targets

Patient IDNormal liverSKOV3-A2MDA-MB-231
IMM-01-001++
IMM-01-002++
IMM-01-003
IMM-01-004++
IMM-01-005
IMM-01-006+
IMM-01-007
IMM-01-008
IMM-02-001+
IMM-02-002
IMM-02-003
IMM-02-004+
IMM-02-005++
IMM-02-006+
IMM-02-007NDNDND

NOTE: Positive response is defined as response to specific peptide greater than 40 spots (out of 106 PBMC) over prevaccination and/or negative control response by ELISpot.

ND: Pt Imm-02-007 received only 3 immunizations and did not return for follow-up testing.